• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 结合基序蛋白 10 通过激活 p53 诱导细胞凋亡并抑制增殖。

RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.

机构信息

Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana, 70112, USA.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, 70112, USA.

出版信息

Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.

DOI:10.1038/s41388-019-1034-9
PMID:31591476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6994357/
Abstract

RNA-binding motif protein 10 (RBM10) is an RNA-binding protein frequently deleted or mutated in lung cancer cells. Recent reports showed that the knockdown of RBM10 in human cancer cells enhances the growth of mouse tumor xenografts, suggesting that RBM10 acts as a tumor suppressor. RBM10 also regulates alternative splicing and controls cancer cell proliferation. However, the underlying molecular mechanisms for its tumor suppression role remain largely unclear. Here, we for the first time report that RBM10 can induce apoptosis and inhibit cancer cell proliferation by activating p53. Our analysis of cancer genomic databases showed that patients with wild-type RBM10 and p53 survive longer than do those with mutated p53 or less RBM10. RBM10 overexpression markedly inhibited mitochondrial respiration, cell migration and proliferation of various cancer cells that harbor wild-type p53. Also, RBM10 overexpression elongated p53's half-life by disrupting MDM2-p53 interaction and subsequently repressing p53 ubiquitination, whereas knockdown of RBM10 decreased p53 stability. Altogether, our results demonstrate that RBM10 inhibits cancer cell proliferation and induces apoptosis in part by blocking the MDM2-p53 feedback loop.

摘要

RNA 结合基序蛋白 10(RBM10)是一种在肺癌细胞中经常缺失或突变的 RNA 结合蛋白。最近的报告表明,在人类癌细胞中敲低 RBM10 会增强小鼠肿瘤异种移植物的生长,这表明 RBM10 作为一种肿瘤抑制因子发挥作用。RBM10 还调节选择性剪接并控制癌细胞增殖。然而,其肿瘤抑制作用的潜在分子机制在很大程度上仍不清楚。在这里,我们首次报道 RBM10 可以通过激活 p53 诱导细胞凋亡并抑制癌细胞增殖。我们对癌症基因组数据库的分析表明,具有野生型 RBM10 和 p53 的患者比具有突变型 p53 或较少 RBM10 的患者存活时间更长。RBM10 的过表达显著抑制了具有野生型 p53 的各种癌细胞的线粒体呼吸、细胞迁移和增殖。此外,RBM10 过表达通过破坏 MDM2-p53 相互作用并随后抑制 p53 泛素化来延长 p53 的半衰期,而 RBM10 的敲低则降低了 p53 的稳定性。总之,我们的结果表明,RBM10 通过阻断 MDM2-p53 反馈环部分抑制癌细胞增殖并诱导细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/ba4dbf22c65e/nihms-1540414-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/0da63be3ab2b/nihms-1540414-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/668175995d72/nihms-1540414-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/b49b6f3ca81d/nihms-1540414-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/78d9810a99e1/nihms-1540414-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/007ace55f3d9/nihms-1540414-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/ba4dbf22c65e/nihms-1540414-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/0da63be3ab2b/nihms-1540414-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/668175995d72/nihms-1540414-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/b49b6f3ca81d/nihms-1540414-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/78d9810a99e1/nihms-1540414-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/007ace55f3d9/nihms-1540414-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1b/6994357/ba4dbf22c65e/nihms-1540414-f0006.jpg

相似文献

1
RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.RNA 结合基序蛋白 10 通过激活 p53 诱导细胞凋亡并抑制增殖。
Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.
2
RBM10, a New Regulator of p53.RBM10,一种新的 p53 调节剂。
Cells. 2020 Sep 16;9(9):2107. doi: 10.3390/cells9092107.
3
RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis.RBM10调节肿瘤细胞凋亡、增殖和转移。
Front Oncol. 2021 Feb 24;11:603932. doi: 10.3389/fonc.2021.603932. eCollection 2021.
4
Functional role of RBM10 in lung adenocarcinoma proliferation.RBM10 在肺腺癌增殖中的功能作用。
Int J Oncol. 2019 Feb;54(2):467-478. doi: 10.3892/ijo.2018.4643. Epub 2018 Nov 22.
5
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability.敲低 RNF2 通过调节 MDM2 和 p53 的稳定性诱导细胞凋亡。
Oncogene. 2014 Jan 23;33(4):421-8. doi: 10.1038/onc.2012.605. Epub 2013 Jan 14.
6
RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.RBM10 通过 RAP1/AKT/CREB 信号通路抑制肺腺癌细胞增殖。
J Cell Mol Med. 2019 Jun;23(6):3897-3904. doi: 10.1111/jcmm.14263. Epub 2019 Apr 6.
7
RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.RNA 结合基序蛋白 10 通过与核糖体蛋白 uL18 和 uL5 结合来失活 c-Myc。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2308292120. doi: 10.1073/pnas.2308292120. Epub 2023 Nov 30.
8
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.E2F-1转录活性是Mdm2拮抗剂诱导人肿瘤细胞系凋亡的关键决定因素。
Oncogene. 2008 Sep 11;27(40):5303-14. doi: 10.1038/onc.2008.164. Epub 2008 Jun 2.
9
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.PHLDB3 蛋白结构域富含 Pleckstrin 同源蛋白通过涉及 p53 的负反馈回路支持肿瘤生长。
Nat Commun. 2016 Dec 23;7:13755. doi: 10.1038/ncomms13755.
10
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.RNA 结合基序蛋白 10 通过调控真核翻译起始因子 4H 的可变剪接抑制肺癌进展。
EBioMedicine. 2020 Nov;61:103067. doi: 10.1016/j.ebiom.2020.103067. Epub 2020 Oct 23.

引用本文的文献

1
LncRNA regulates GRP78 and DDX5 axis to promote JEV infection and cell death.长链非编码RNA通过调控GRP78和DDX5轴促进日本脑炎病毒感染及细胞死亡。
J Virol. 2025 May 20;99(5):e0006625. doi: 10.1128/jvi.00066-25. Epub 2025 Apr 24.
2
Alterations in Gene Expression and Alternative Splicing Induced by Plasmid-Mediated Overexpression of GFP and Within the A549 Cell Line.质粒介导的绿色荧光蛋白(GFP)在A549细胞系中过表达所诱导的基因表达和可变剪接变化
Int J Mol Sci. 2025 Mar 25;26(7):2973. doi: 10.3390/ijms26072973.
3
RBM10 suppresses malignant transformation in endometrial cancer via the Hippo-YAP signaling pathway.

本文引用的文献

1
Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.癌症突变的核糖体蛋白L22(RPL22/eL22)通过阻断p53-MDM2回路来抑制癌细胞存活。
Oncotarget. 2017 Oct 6;8(53):90651-90661. doi: 10.18632/oncotarget.21544. eCollection 2017 Oct 31.
2
The MDM2-p53 pathway revisited.重新审视MDM2-p53信号通路。
J Biomed Res. 2013 Jul;27(4):254-71. doi: 10.7555/JBR.27.20130030. Epub 2013 Jun 6.
RBM10通过Hippo-YAP信号通路抑制子宫内膜癌的恶性转化。
Am J Transl Res. 2025 Feb 25;17(2):1480-1494. doi: 10.62347/FHXK9469. eCollection 2025.
4
RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a BBB model of EGFR mutant lung adenocarcinoma.在表皮生长因子受体(EGFR)突变型肺腺癌的血脑屏障模型中,RNA结合基序蛋白10(RBM10)缺陷通过调节鞘脂代谢促进脑转移。
J Exp Clin Cancer Res. 2025 Mar 11;44(1):95. doi: 10.1186/s13046-025-03347-1.
5
RBM10 Is a Biomarker Associated with Pan-Cancer Prognosis and Immune Infiltration: System Analysis Combined with In Vitro and Vivo Experiments.RBM10是一种与泛癌预后和免疫浸润相关的生物标志物:结合体外和体内实验的系统分析
Oxid Med Cell Longev. 2022 Nov 28;2022:7654937. doi: 10.1155/2022/7654937. eCollection 2022.
6
Down regulation of RBM10 promotes proliferation and metastasis via miR-224-5p/RBM10/p53 feedback loop in lung adenocarcinoma.RBM10的下调通过miR-224-5p/RBM10/p53反馈环促进肺腺癌的增殖和转移。
Heliyon. 2024 Jul 22;10(15):e35001. doi: 10.1016/j.heliyon.2024.e35001. eCollection 2024 Aug 15.
7
Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma.利用 DNA 复制应激靶向肺腺癌中的 RBM10 缺陷。
Nat Commun. 2024 Jul 30;15(1):6417. doi: 10.1038/s41467-024-50882-0.
8
Expression pattern, immune signature, and prognostic value of RBM10 in human cancers.RBM10在人类癌症中的表达模式、免疫特征及预后价值
Histol Histopathol. 2025 Apr;40(4):493-508. doi: 10.14670/HH-18-790. Epub 2024 Jul 4.
9
Investigation of mutation and its associations with clinical and molecular characteristics in -mutant and -wildtype lung adenocarcinoma.-突变型和-野生型肺腺癌中突变情况及其与临床和分子特征的相关性研究。
Heliyon. 2024 May 31;10(11):e32287. doi: 10.1016/j.heliyon.2024.e32287. eCollection 2024 Jun 15.
10
RNA splicing alterations in lung cancer pathogenesis and therapy.肺癌发病机制与治疗中的RNA剪接改变
Cancer Pathog Ther. 2023 Apr 28;1(4):272-283. doi: 10.1016/j.cpt.2023.04.004. eCollection 2023 Oct.